Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Isotretinoin can effectively reduce symptoms of frontal fibrosing alopecia.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

A woman with severe angioedema improved significantly after treatment with rituximab.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

The document concludes that scalp conditions have various causes and can present in many different ways.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Treatment with specific medications and supplements improved skin condition and hair regrowth in an Akita with sebaceous adenitis.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

The model and estimator can predict drug exposure in kidney transplant patients well.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Vitamin A affects hair loss and immune response in alopecia areata.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.